Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Fox Chase Chemical Diversity Center Inc. and University of Pittsburgh have jointly described new proteolysis targeting chimeras (PROTACs) consisting of Nef (HIV-1)-targeting moiety covalently linked ...

New guidelines update ART choices, endorse long-acting injectables, refine infant feeding advice, and prioritise shorter TB ...

Researchers analyzed 22 recent studies exploring HIV-related outcomes in the context of climate change and identified several links between extreme weather events and HIV prevention and care. New ...

SEATTLE – October 27, 2025 –Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they ...

Darwin Tenoria first learned about HIV when he was on his deathbed. He was 27 and weighed just 70 pounds. "I died for two minutes and I was revived in the hospital," he remembers. When he woke up, he ...

I came of age during the height of the AIDS crisis in the '90s. I was just starting my career in the pharmaceutical industry as the epidemic hit its peak, and the anxiety and concern surrounding it ...